- 0 items in basket
- Total £0
- $0 / €0
- View Basket
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharma Chemicals
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
- Market Reports
Reportbuyer.com helps you stay ahead with advanced reports on Diseases. Information includes Competitive Positioning, Stakeholder Opinions and Future Market Watch.
Diseases Market Research
| Brief Report: Interleukin-17 (IL-17R) and IL-17 Receptor Antagonists | Feb 2010 | £435 |
| Chronic Obstructive Pulmonary Disease (COPD) Drug Pipeline Analysis and Market Forecasts to 2016 | Feb 2010 | £1,255 |
| Alzheimer's Disease New Drugs, Markets and Companies | Feb 2010 | £2,005 |
| Targeting Cancer Stem Cells Therapeutic Strategies and Pipeline Developments (2010) | Jan 2010 | £1,599 |
| Pancreatic Cancer Drug Pipeline Update 2010 | Jan 2010 | £1,310 |
| Ovarian Cancer Drug Pipeline Update 2010 | Jan 2010 | £1,310 |
| Colorectal Cancer Drug Pipeline Update 2010 | Jan 2010 | £1,310 |
| Renal Cancer Drug Pipeline Update 2010 | Jan 2010 | £1,310 |
| Hematological Cancers Drug Pipeline Update 2010 | Jan 2010 | £1,750 |
| Lung Cancer Drug Pipeline Update 2010 | Jan 2010 | £1,310 |
| Prostate Cancer Drug Pipeline Update 2010 | Jan 2010 | £1,310 |
| Analytical Tool - Lung Cancer | Jan 2010 | £2,710 |
| Bladder Cancer Drug Pipeline Update 2010 | Jan 2010 | £875 |
| The Cancer Market Outlook To 2014 Competitive landscape, market size, pipeline analysis and growth opportunities | Jan 2010 | £2,405 |
| Breast Cancer Market– An Analysis | Jan 2010 | £500 |
| Head and Neck Cancer Drug Pipeline Update 2010 | Jan 2010 | £1,310 |
| Cancer Vaccines Drug Pipeline Update 2010 | Jan 2010 | £1,310 |
| Brain Cancer Drug Pipeline Update 2010 | Jan 2010 | £1,310 |
| Analytical Tool - Melanoma | Jan 2010 | £2,710 |
| Liver Cancer Drug Pipeline Update 2010 | Jan 2010 | £875 |
| Breast Cancer Drug Pipeline Update 2010 | Jan 2010 | £1,310 |
| Analytical Tool - Colorectal Cancer | Jan 2010 | £2,710 |
| Analytical Tool - Cancer Vaccines | Jan 2010 | £2,710 |
| Analytical Tool - Breast Cancer | Jan 2010 | £2,710 |
| Treating Neuropathic Pain A Global Study of Clinical Strategies | Jan 2010 | £3,950 |
| Analytical Tool - Cancer Therapeutic Antibodies | Jan 2010 | £3,495 |
| The Future of The Diabetes Care Devices Market to 2016 The Key Demand Drivers Remain Intact | Jan 2010 | £2,195 |
| Analytical Tool- Cancer Immunotherapy | Jan 2010 | £4,330 |
| Analytical Tool - Lymphoma | Jan 2010 | £2,710 |
| Analytical Tool - Hematological Cancers | Jan 2010 | £5,205 |
| Global Peritoneal Dialysis Market Strategic Analysis and Opportunity Assessment | Jan 2010 | £2,195 |
| Analytical Tool - Leukemia | Jan 2010 | £2,710 |
| Diabetes Market Forecast to 2015 | Jan 2010 | £6,120 |
| R&D Pipeline News - Technology Edition: 1-Year Subscription Periodical | Jan 2010 | |
| Analytical Tool - Prostate Cancer | Jan 2010 | £2,710 |
| R&D Pipeline News - Therapeutic Area Edition: 1-Month Subscription Periodical | Jan 2010 | |
| R&D Pipeline News - Technology Edition: 1-Month Subscription Periodical | Jan 2010 | |
| R&D Pipeline News - Therapeutic Area Edition: 1-Year Subscription Periodical | Jan 2010 | |
| U.S. Colorectal Cancer Market | Dec 2009 | £3,765 |
| Stakeholder Opinions: Biomarkers in Rheumatology Awaiting the next step towards personalized medicine | Dec 2009 | £2,385 |
| Molecular Diagnostics in Cancer Testing | Dec 2009 | £2,130 |
| Pipeline Insight: Multiple Sclerosis Risk-benefit ratio under the spotlight for potent pipeline drugs | Dec 2009 | £7,150 |
| The Gastrointestinal Market Outlook To 2014 Market dynamics, competitive landscape, emerging therapies | Dec 2009 | £2,405 |
| The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis | Dec 2009 | £2,195 |
| Stakeholder Insight: Cancer Pain Physician survey highlights inadequacies in education and treatment | Dec 2009 | £9,535 |
| Commercial Insight: Antibacterials Opportunities in the hospital sector contrast with the lack of innovation in community market | Dec 2009 | £9,535 |
| Pipeline Insight: Biologic Targeted Cancer Therapies Next generation jostles for market position | Dec 2009 | £7,150 |
| Stakeholder Insight: Non-Hodgkin's Lymphomas Diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) | Dec 2009 | £9,535 |
| Lung Cancer Therapeutics Market Outlook and Pipeline Analysis | Nov 2009 | £940 |
| U.S. Overactive Bladder Market | Nov 2009 | £3,765 |
| Monoclonal Antibody Based Products Global Trends | Nov 2009 | £1,880 |
| French Infectious Disease Testing Market | Nov 2009 | £3,450 |
| Diabetes Diagnostics A Global Market Perspective | Nov 2009 | £1,880 |
| Pain Management Global Trends | Nov 2009 | £1,880 |
| Global Infectious Disease Testing Market Facilities, Test Volume, and Sales Forecasts by Country | Nov 2009 | £535 |
| Infectious Disease Testing Technologies Market Applications of Current and Emerging Technologies | Nov 2009 | £535 |
| Infectious Disease Testing Product Development Opportunities, Market Penetration Strategies, Entry Barriers and Risks | Nov 2009 | £315 |
| Alzheimer's and Parkinson's Diseases A Global Update of Market Trends & Opportunities | Nov 2009 | £1,880 |
| Hiv/Aids Testing World Review | Nov 2009 | £1,880 |
| TGF-R Agonists and Antagonists Competitor Analysis | Nov 2009 | £175 |
| Leading Infectious Disease Market Players Insightful Profiles of Major Suppliers and Recent Market Entrants | Nov 2009 | £1,130 |
| Infectious Disease Testing Instrumentation Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers | Nov 2009 | £470 |
| CNS Therapeutics A World Market Review | Nov 2009 | £1,880 |
| Proteasome Inhibitors Competitor Analysis | Nov 2009 | £87 |
| FSH, hCG and LH - Therapeutic Proteins for Assisted Reproductive Technology (ART) Competitor Analysis | Nov 2009 | £175 |
| German Infectious Disease Testing Market | Nov 2009 | £3,450 |
| Spanish Infectious Disease Testing Market | Nov 2009 | £3,450 |
| US Infectious Disease Testing Market | Nov 2009 | £5,895 |
| Hemoglobin A1c Monitoring Global Market Trends | Nov 2009 | £1,880 |
| UK Infectious Disease Testing Market | Nov 2009 | £3,450 |
| Japanese Infectious Disease Testing Market | Nov 2009 | £4,390 |
| Italian Infectious Disease Testing Market | Nov 2009 | £3,450 |
| Shaping the Marketplace to Support Successful Oncology Product Launches Tactics for Educating KOLs, Physicians, Patients and Payers | Nov 2009 | £5,020 |
| Prostate Cancer Therapeutics A Global Market Perspective | Nov 2009 | £1,880 |
| CXCR and CXCL Agonists and Antagonists Competitor Analysis | Nov 2009 | £260 |
| Current and Emerging Infectious Disease Tests Emerging Assays and Companies Developing New Technologies and Products | Nov 2009 | £2,415 |
| Cancer Therapies Global Market Opportunities | Nov 2009 | £1,880 |
| U.S. Market for Diabetes Monitoring, Treatment and Drug Delivery 2010 | Nov 2009 | £4,700 |
| Heat shock protein 90 (Hsp90) Inhibitors Competitor Analysis | Nov 2009 | £175 |
| Antidiabetics in Australia Market Forecast | Oct 2009 | £3,575 |
| Pipeline Insight: Colorectal Cancer Growing trend towards personalized medicine | Oct 2009 | £7,150 |
| Commercial Insight: Antidiabetics in Australia Reimbursement status shapes novel classes | Oct 2009 | £3,575 |
| Infectious Diseases Drugs Markets | Oct 2009 | £2,130 |
| Competitor Analysis: EGF-R Agonists and Antagonists | Oct 2009 | £260 |
| Worldwide Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals), The | Oct 2009 | £2,195 |
| Chinese Markets for Bladder Cancer Treatment Drugs | Sep 2009 | £2,510 |
| Competitor Analysis: Her2 Receptor Antagonists | Sep 2009 | £220 |
| Chinese Markets for Brain Cancer Treatment Drugs | Sep 2009 | £2,510 |
| Chinese Markets for Cervical Cancer Treatment Drugs | Sep 2009 | £2,510 |
| The Diabetes Market Outlook To 2014 Market Dynamics, Competitive Landscape, Emerging Therapies | Sep 2009 | £2,405 |
| Chinese Markets for Colon Cancer Treatment Drugs | Sep 2009 | £2,510 |
| World Neurodegenerative Diseases Market 2009-2024 | Sep 2009 | £1,499 |
| The UK Cancer Diagnostics Market | Sep 2009 | £2,570 |
| Cancer Diagnostic Technologies Assessment of Current and Emerging Technologies, and Their Potential Market Applications | Sep 2009 | £1,065 |
| The Italian Cancer Diagnostics Market | Sep 2009 | £2,570 |
| Cancer Diagnostic Testing A Global Market Overview - Facilities, Test Volumes, and Sales Forecasts by Country | Sep 2009 | £410 |
| The German Cancer Diagnostics Market | Sep 2009 | £2,570 |
| The Spanish Cancer Diagnostics Market | Sep 2009 | £2,570 |
| Leading Cancer Diagnostics Market Players Strategic Assessments of Major Suppliers and Emerging Market Entrants | Sep 2009 | £1,380 |
| The US Cancer Diagnostics Market | Sep 2009 | £4,640 |
Refine this search
Price
Published
Availability
Product type
© 2010| Report Buyer is a trading name for Piribo Ltd. Registered in England and Wales No. 05051530 | VAT Reg No. GB 839 4556 85
